Cytokines in the treatment and prevention o... [Adv Exp Med Biol. 2003] - PubMed

Save items

loading

Related citations in PubMed

Review IL-7 and IL-15: therapeutic cytokines for immunodeficiency. [Trends Immunol. 2005]
Review IL-7 and IL-15: therapeutic cytokines for immunodeficiency.
Alpdogan O, van den Brink MR. Trends Immunol. 2005 Jan; 26(1):56-64.
Review CD1d-mediated antigen presentation to natural killer T (NKT) cells. [Crit Rev Immunol. 2003]
Review CD1d-mediated antigen presentation to natural killer T (NKT) cells.
Brutkiewicz RR, Lin Y, Cho S, Hwang YK, Sriram V, Roberts TJ. Crit Rev Immunol. 2003; 23(5-6):403-19.
Review IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. [J Exp Clin Cancer Res. 2006]
Review IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances.
Shanmugham LN, Petrarca C, Frydas S, Donelan J, Castellani ML, Boucher W, Madhappan B, Tete' S, Falasca K, Conti P, et al. J Exp Clin Cancer Res. 2006 Dec; 25(4):529-36.
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. [Arthritis Res Ther. 2007]
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.
de Rham C, Ferrari-Lacraz S, Jendly S, Schneiter G, Dayer JM, Villard J. Arthritis Res Ther. 2007; 9(6):R125.
The CD1d natural killer T-cell antigen presentation pathway is highly conserved between humans and rhesus macaques. [Immunogenetics. 2003]
The CD1d natural killer T-cell antigen presentation pathway is highly conserved between humans and rhesus macaques.
Kashiwase K, Kikuchi A, Ando Y, Nicol A, Porcelli SA, Tokunaga K, Omine M, Satake M, Juji T, Nieda M, et al. Immunogenetics. 2003 Feb; 54(11):776-81. Epub 2003 Feb 6.

See reviews... See all...

Cited by 2 PubMed Central articles

T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation. [Immunotherapy. 2010]
T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation.
Koulmanda M, Strom TB. Immunotherapy. 2010 Jul; 2(4):431-6.
Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. [Proc Natl Acad Sci U S A. 2007]
Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts.
Koulmanda M, Budo E, Bonner-Weir S, Qipo A, Putheti P, Degauque N, Shi H, Fan Z, Flier JS, Auchincloss H Jr, et al. Proc Natl Acad Sci U S A. 2007 Aug 7; 104(32):13074-9. Epub 2007 Aug 1.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cytokines in the treatment and prevention of autoimmune responses-a role of IL-1...
Cytokines in the treatment and prevention of autoimmune responses-a role of IL-15.
Adv Exp Med Biol. 2003 ;520:87-95.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Cytokines in the treatment and prevention of autoimmune responses-a role of IL-15.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information